How is the Indaptus Therapeutics Inc today?

The Indaptus Therapeutics Inc today is trading in the down by -18.18% at 0.27.

How has Indaptus Therapeutics Inc performed historically?

The Indaptus Therapeutics Inc is currently trading down -18.18% on an intraday basis in the past week the index fell -15.62%. The index has been down -62.50% in the past quarter and fell -88.00% in the past year. You can view this in the overview section.

What is Indaptus Therapeutics Inc Annual Net Profit?

Indaptus Therapeutics Inc Annual Net Profit rose 2.6% in the last year to $15.02 M. Its sector's average net profit growth for the last fiscal year was -14.05%.

What is Indaptus Therapeutics Inc Price to Earning Ratio?

Indaptus Therapeutics Inc Price to Earning Ratio is -0.27, which is negative.

What is Indaptus Therapeutics Inc Stock Price?

Indaptus Therapeutics Inc Stock Price fell 88% and underperformed its sector by 243.23% in the past year.

What is Indaptus Therapeutics Inc Quarterly Net profit?

Indaptus Therapeutics Inc Quarterly Net profit fell 19.07% YoY to $4.53 M. Its sector's average net profit growth YoY for the quarter was -236.06%.

What is Indaptus Therapeutics Inc Debt to Equity Ratio?

Indaptus Therapeutics Inc Debt to Equity Ratio of 0.02 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Indaptus Therapeutics Inc Return on Equity(ROE)?

Indaptus Therapeutics Inc Return on Equity(ROE) for the last financial year was -187.52%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Indaptus Therapeutics Inc Mutual Fund Holding?

Indaptus Therapeutics Inc Mutual Fund Holding decreased by 0.12% in the last quarter to 2.73.

What is Indaptus Therapeutics Inc Institutional Holding?

Indaptus Therapeutics Inc Institutional Holding increased by 0.23% in the last quarter to 4.3.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : MAJOR PHARMACEUTICALS
INDAPTUS THERAPEUTICS INC

Indaptus Therapeutics Inc XNAS: INDP

Indaptus Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Indaptus Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Indaptus Therapeutics Inc
Rating: 0.93783325
Author: Trendlyne DVM scores

about

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ...

0.27 -0.06 (-18.18%)

New 52W Low today

349.0K

XNAS Volume

XNAS 20 Jun, 2025 4:19 PM (EDT)

Not Eligible

Expensive Valuation

9.8 / 100

Technically Bearish

27.7 / 100

No estimates available

Indaptus Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Indaptus Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ...

New 52W Low today

SWOT Analysis

Indaptus Therapeutics Inc Live Price Chart

Indaptus Therapeutics Inc FAQ

How is Indaptus Therapeutics Inc today?

Indaptus Therapeutics Inc today is trading in the red, and is down by -18.18% at 0.27.

How has Indaptus Therapeutics Inc performed historically?

Indaptus Therapeutics Inc is currently trading down -18.18% on an intraday basis. In the past week the stock fell -15.62%. stock has been down -62.50% in the past quarter and fell -88.00% in the past year. You can view this in the overview section.